It is estimated that 1 in 5 people will develop some type of skin cancer by age 70. The good news is that 99 percent of all cases are curable if they are diagnosed and treated early enough. Read on to learn about one expecting mother's journey to recovery. You also can learn about the latest advancements in melanoma cancer care and treatment at a free VIRTUAL event on Monday, May 3 at 5:30 p.m. To register, visit LVHN.org/MelanomaEvent.
Mariah Veley of Orefield was eagerly expecting her second child when she noticed a suspicious mole on her scalp in February 2018. A biopsy revealed a locally advanced melanoma requiring immediate treatment.
“It was an intense time,” says Veley, who was then 28 with a 2-year-old son, Pierce. “I was 22 weeks pregnant and had an autoimmune disease called ulcerative colitis (UC) that would make cancer treatment extremely tricky.”
Extraordinary treatment team
Veley attended a multidisciplinary cancer clinic at Lehigh Valley Cancer Institute to discuss treatment with her team of oncologists, surgeons, maternal fetal medicine specialists and nurse navigator Angela Miller, RN.
After consulting with specialists with Memorial Sloan Kettering (MSK) Cancer Alliance, her team decided to remove the lesion and perform a sentinel lymph node biopsy to determine whether it had spread. However, they would delay other potentially harmful treatments until after delivery.
On March 15, head and neck surgeon Chetan Nayak, MD, with LVPG Ear, Nose and Throat, injected the 2-centimeter-by-4-millimeter deep lesion with radiotracer. Sentinel lymph nodes were located in the right preauricular area in front of her ear and upper neck. He removed those along with the lesion.
“Three sentinel lymph nodes were positive, meaning this was stage 3 melanoma,” Nayak says.
Post-delivery success
In June 2018, Veley underwent a cesarean section at 37 weeks to begin further treatment. Baby Scarlett was born without complications.
Next, plastic surgeon Randolph Wojcik, MD, with LVPG Plastic and Reconstructive Surgery, performed reconstructive surgery on Veley's scalp to hide scarring. She also began taking targeted inhibitor drugs to block a BRAF gene mutation in her tumor that was promoting uncontrolled cell growth.
“Mariah took inhibitors for nine months,” says hematologist oncologist Suresh Nair, MD, with LVHN Hematology Oncology. “She stopped after a severe UC flare, but she's now cancer-free.”
Veley credits her “world-class” medical team for helping her thrive during therapy. Not only did she continue working and caring for her children, she even started a nonprofit and took up aerial acrobatics, where she won a competition.
“My providers treated me like a person, not just a diagnosis,” she says. “I couldn't be more fortunate."
Watch Mariah's video.
Lehigh Valley Cancer Institute is the only local member in the Memorial Sloan Kettering Cancer Alliance, and our doctors are ready to partner with you. Learn about the latest advancements in melanoma cancer care and treatment at a free VIRTUAL event on Monday, May 3 at 5:30 p.m. To register, visit LVHN.org/MelanomaEvent.
Lehigh Valley Health Network | lvhn.org
This post is a sponsored collaboration between Lehigh Valley Health Network and Lehigh Valley Style.
